Ephraim Resources Limited Share Price

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote Australian S.E. 04:47:55 28/02/2017 GMT 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.68M 2.49M 2.29M 4.32M 294M 4.39M 29.38M 11.53M 146M 11.57M 11.31M 491M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.15M 2.94M 2.7M 5.09M 346M 5.17M 34.61M 13.58M 172M 13.63M 13.33M 578M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 27/01/2020
Director TitleAgeSince
Director/Board Member 60 16/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
-1.40%+2.59%-1.71%+11.28% 48.53B
-2.41%-0.90%+411.96%+495.33% 39.87B
-1.16%+12.96%+28.81%+7.25% 38.68B
-1.88%-3.03%+5.69%+53.00% 35.13B
-1.74%+5.12%+14.44%+41.77% 29.79B
-0.21%-4.04%+36.40%+125.75% 16.11B
-2.85%-3.92% - - 16.08B
-0.64%+2.65%+3.40%+13.11% 13.61B
-1.19%-1.32%-1.73%-34.37% 12.62B
Average +8.65%+10.95%+62.16%+89.14% 25.04B
Weighted average by Cap. -1.60%+2.04%+79.78%+108.61%

Financials

2017 2018
Net sales 16.01K 13.92K 12.95K 11.89K 22.46K 1.53M 22.81K 153K 59.93K 761K 60.13K 58.81K 2.55M 124 107.79 100.33 92.12 173.96 11.84K 176.65 1.18K 464.16 5.89K 465.69 455.46 19.76K
Net income -481K -418K -389K -357K -675K -45.91M -685K -4.59M -1.8M -22.86M -1.81M -1.77M -76.64M -976K -848K -789K -725K -1.37M -93.13M -1.39M -9.3M -3.65M -46.36M -3.66M -3.58M -155M
Net Debt 497K 432K 402K 369K 697K 47.42M 708K 4.74M 1.86M 23.61M 1.87M 1.82M 79.16M 548K 477K 444K 407K 769K 52.34M 781K 5.23M 2.05M 26.06M 2.06M 2.01M 87.38M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-